These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2650075)

  • 21. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
    J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model.
    Imanishi M; Matsuura T; Hara Y; Tahara H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1958-9. PubMed ID: 7520615
    [No Abstract]   [Full Text] [Related]  

  • 25. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract]   [Full Text] [Related]  

  • 28. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
    [No Abstract]   [Full Text] [Related]  

  • 29. The different influences of allosensitization and xenosensitization on cellular rejection.
    Fryer JP; Chen S; Johnson EM; Sun LH; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):674. PubMed ID: 8623338
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclosporin therapy for treatment of rat heart allograft rejection.
    Westra AL; Petersen AH; Prop J; Wildevuur CR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):963-4. PubMed ID: 2650301
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 34. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of deflazacort, a glucocorticoid with bone-sparing properties, on mixed lymphocyte response and skin graft rejection.
    Mistrello G; Mapelli E; Galliani G; Cristina T; Assandri A
    Transplantation; 1984 Aug; 38(2):192-4. PubMed ID: 6235649
    [No Abstract]   [Full Text] [Related]  

  • 36. Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats.
    Wang D; Kleist C; Ehser S; Opelz G; Terness P
    Transplantation; 2006 Dec; 82(11):1537-40. PubMed ID: 17164729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D; Wood KJ; Carter NP; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 39. Heterotopic rat heart transplantation to the iliac vessels.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Akiyama T; Kurita T
    Transplant Proc; 1994 Aug; 26(4):2318-9. PubMed ID: 7520632
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.